See my new post on the website of the National Eczema Association. It's about researchers at the University of Rochester who are conducting a clinical trial of Actos, a drug originally developed to treat diabetes but which looks like it could also repair the skin barrier and help eczema patients.
I learned about Actos when I spoke to Alice Pentland, who directs the new Skin Barrier Research Consortium at Rochester. I was going to write about the consortium but got too excited about Actos instead. I'll have to cover the research group in a second post.
This comment has been removed by a blog administrator.
ReplyDeleteI should note that it's illegal (and, if prosecuted, extremely expensive) for drug companies to promote off-label scrips for uses not approved by the FDA. See the NYT story today about Glaxo's $3 billion (!!!) fine for promoting Paxil and Wellbutrin.
ReplyDeletehttp://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?_r=1&hp
Great post, and great website. Thanks for the information! drug rehab
ReplyDelete